Beyond Tyrosinase: Why Pigment Correction Requires a Multi-Pathway Approach

Tyrosinase Deserves the Attention

Tyrosinase plays a central role in melanin synthesis, and ingredients that influence melanogenesis have a well-established place in pigment management. I use this pathway in my own treatment planning and formulation thinking.

I just don’t think the conversation should end there.

Once melanin is produced inside the melanocyte, it is packaged into melanosomes and transferred to keratinocytes. That transfer gives us another place to intervene.

Niacinamide is a great example. In a human clinical study, topical niacinamide significantly decreased hyperpigmentation compared with vehicle. Interestingly, researchers did not find that niacinamide directly inhibited tyrosinase activity or melanogenesis. In laboratory models, they observed inhibition of melanosome transfer from melanocytes to keratinocytes.

We can influence the appearance of pigmentation without every ingredient having to work directly on tyrosinase.

It also changes how I look at a pigment formula. I don’t necessarily want five ingredients all trying to do essentially the same thing. I want to understand what each one brings to the formula and why it’s there.

We Also Have to Ask Why the Pigment Is There

Post-inflammatory hyperpigmentation is one of the clearest examples of why we need to think beyond melanin production.

PIH can follow acne, dermatitis, injury, and aesthetic procedures. Research has associated its severity with factors including inherent skin color, the degree and depth of inflammation, and disruption at the dermoepidermal junction.

For those of us performing peels, lasers, microneedling and other corrective treatments, this deserves our attention. We’re intentionally creating a controlled response in the skin. We also need to recognize when that response becomes more inflammatory than necessary, particularly in someone already prone to PIH.

I’m certainly not suggesting that we stop resurfacing pigment-prone skin. Resurfacing can be incredibly useful. But more aggressive doesn’t automatically mean more corrective. Sometimes it just means the skin is angrier with us.

When treating pigmentation, how the skin responds to the treatment is part of the treatment.

The Melanocyte Has Neighbors

Melanocytes aren’t working in isolation. Keratinocytes, fibroblasts, and inflammatory mediators can participate in signaling that influences melanocyte behavior.

Melasma is a good example of how complex that conversation can get.

Research into melasma has identified changes involving the basement membrane, vascularization, mast cells, solar elastosis, and fibroblasts, along with oxidative stress and changes within the skin microenvironment. Barrier dysfunction has also been reported.

That doesn’t mean we suddenly need to build a protocol targeting every pathway mentioned in a melasma paper. We’d need a very large treatment cart.

But reducing melasma to “too much tyrosinase” doesn’t adequately describe what is happening in the skin.

We see versions of this clinically all the time. Two clients can walk in with brown patches on their face and need very different treatment plans. PIH following acne, recurrent melasma, and photodamage shouldn’t automatically get dropped into the same pigment bucket.

Resurfacing Still Has a Job

Chemical peels have substantial clinical literature behind their use in pigment management. A 2024 systematic review evaluated 24 studies involving 1,075 patients and found chemical peels to be safe and effective in melasma management, although the protocols varied considerably.

I still believe resurfacing has an important place in pigment correction. But I want to know why I’m resurfacing, how much inflammation I’m creating in the process, and what I’m doing between treatments to support the rest of the pigment strategy.

Controlled resurfacing can be a useful component of a pigment protocol, particularly when epidermal pigmentation is part of what we’re treating. It doesn’t replace the need to think about melanogenesis, pigment transfer, inflammation, photoprotection, or factors that may be contributing to recurrence.

The best pigment plan isn’t necessarily the strongest treatment. It’s the one where each part of the protocol has a reason for being there.

Multi-Pathway Doesn’t Mean Throw Everything at It

There is one potential problem with talking about pigmentation this way. “Multi-pathway” can quickly turn into a very long ingredient list.

More ingredients don’t automatically make a formula more sophisticated.

There is good human research behind some combination approaches. Niacinamide, for example, has been studied alongside N-acetyl glucosamine. In a randomized, double-blind, vehicle-controlled study involving 202 women, a formulation containing 4% niacinamide and 2% N-acetyl glucosamine produced greater improvement in irregular facial pigmentation than vehicle.

That study doesn’t mean everyone needs that particular combination, nor does it prove that every multi-ingredient approach is better. It does give us another example of why formulation should be intentional.

For me, multi-pathway thinking is much more about intention than quantity.

What type of pigmentation am I looking at? What is likely contributing to it? What am I trying to accomplish with the peel, laser, or other treatment I’m performing? What does the home-care formula contribute? Am I creating unnecessary irritation while trying to correct a condition that may already be influenced by inflammation?

Those questions are more useful to me than looking for one hero ingredient to do everything.

Looking at the Whole Pigment Process

We have a much broader understanding of pigment biology today. That doesn’t make tyrosinase inhibition any less valuable. It gives us more of the picture.

Melanin production, melanosome transfer, inflammatory signaling, oxidative stress, and the surrounding skin environment can all be relevant, but their roles won’t be identical for every type of dyschromia or every client.

And I think that’s where pigment correction is headed.

We don’t need to find the next ingredient that replaces tyrosinase inhibition. We need to get better at understanding the pigment in front of us and deciding which parts of the process we actually need to influence.

The next time you’re looking at a stubborn pigment case, don’t ask only, “What’s the best brightening ingredient?”

Ask, “What part of the pigment process am I trying to influence?”

The answer may change your entire treatment plan.